Q-omics provides the consensus-scored NIPA2P2 profile across patient tissues and cancer cell-line models. NIPA2P2 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in PAAD. Additionally, NIPA2P2 RNA expression shows 5,955 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight PAAD, and STAD as cancer lineages where NIPA2P2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for NIPA2P2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes NIPA2P2 survival associations across molecular data types. NIPA2P2 RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

NIPA2P2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	PAAD (63)	view →

This table ranks reproducible NIPA2P2 RNA expression–survival associations across cancer types. High NIPA2P2 expression shows unfavorable associations in PAAD, KIRC, PCPG, UCEC and SARC, but favorable associations in OV. The PAAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .012). Together, the overview and detailed table identify PAAD as the clearest survival context for NIPA2P2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.231	0.480	.012	63	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
OV	DFS	Tertile	III,IV	0.285	0.140	.022	36	view →
PCPG	OS	Tertile	All	0.078	0.955	<.001	36	view →
UCEC	DFS	Tertile	All	0.748	0.902	.002	36	view →
SARC	DFS	Tertile	All	0.135	0.617	<.001	30	view →

Pink = unfavorable, green = favorable. all 8 lineages →

NIPA2P2-PAAD (DFS)

Kaplan–Meier survival curve for NIPA2P2 RNA expression in PAAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with NIPA2P2 in patient tissues and cancer cell lines. In patient samples, NIPA2P2 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,955	STAD (5732)	view →
RNA	5,014	LUSC (2335)	view →